COGSTATE LTD (CGS)
Latest AI Signal: BUY
Status: AGING
Days Old: 6
Confidence: 65%
Date: 15-05-2026
Price: $2.510
Last Price: $2.510
Post-Signal Peak Price: $2.530
Latest COGSTATE LTD(CGS) News
05 May 2026, 05:34 AM
As the Australian share market enters Week 19 with a cautious tone, investors are closely watching the Reserve Bank of Australia's upcoming decision on interest rates, which could influence market dynamics. In this environment of uncertainty and fluctuating indices, identifying undervalued stocks ca
30 Mar 2026, 06:36 AM
The Australian market is experiencing a challenging period, with shares poised for a decline amid geopolitical tensions and natural disruptions, such as the impact of Tropical Cyclone Narelle on energy operations. In this environment, identifying high growth tech stocks requires a focus on companies
03 Nov 2025, 06:33 AM
The Australian stock market is showing resilience, with shares moving toward a modest gain despite global uncertainties and mixed signals from major economies like the U.S. and China. In such an environment, identifying promising small-cap stocks can be particularly rewarding, as these companies oft
Chart available once enough post-signal price data is available.
BUY Confidence Medium
AI Confidence - 65 % model confidence
Business Overview
Cogstate Ltd is a global leader in cognitive science technology, providing digital cognitive testing solutions primarily for clinical trials, healthcare, and research settings. The company holds a strong market position with proprietary technology used by pharmaceutical companies and research institutions to assess brain health and cognitive function efficiently and accurately.
Financial Analysis
| Cash Flow | Moderate |
| Debt | Low |
| Profitability | Moderate |
| Revenue Trend | Uptrend |
Technical Analysis
| Trend | Bullish |
| Momentum | Moderate |
| RSI Signal | Neutral |
| Support Level | $ 2.30 |
| Resistance Level | $ 2.75 |
Valuation
Valuation - Fairly Valued
The stock trades at a reasonable multiple relative to its growth prospects and industry peers, reflecting moderate upside potential.
Catalysts
• Expansion into new markets and partnerships with major pharmaceutical companies
• Advancements in digital cognitive assessment technology increasing adoption
Recommendation
Action - Buy
Timeframe - Medium Term
Cogstate Ltd presents a compelling growth opportunity driven by its niche cognitive testing technology and expanding client base. The company’s improving financials and bullish technical signals support a medium-term buy recommendation.